Fingerprint
Dive into the research topics of 'Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically